Sign In
Buy LLY
$1,131.42
+6.15 (+0.547%)
At Close: Jun 05, 2026
Tech market values fall on AI costs and recession fears; Eli Lilly, Berkshire gain
08:09am, Monday, 02'nd Sep 2024
Market values of major tech firms declined in August amid concerns over escalating artificial intelligence infrastructure costs and rising recession risks that would make the stocks particularly vulne
3 GLP-1 Stocks to Buy Now For Big Long-Term Gains
09:12am, Sunday, 01'st Sep 2024
The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive.
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now
07:20am, Sunday, 01'st Sep 2024
These businesses are capitalizing on the future of their respective industries. Eli Lilly is already experiencing untold success amid the GLP-1 inhibitor drug boom, but the nearly 150-year-old company
The Next 3 Stocks Ready to Cross the Trillion-Dollar Threshold
08:55am, Saturday, 31'st Aug 2024
Remember when a stock becoming valued at $1 trillion was a big thing?
S&P 500 Giants Meta, Eli Lilly Lead 5 Stocks Near Buy Points
08:00am, Saturday, 31'st Aug 2024
Meta, Costco and Eli Lilly along with two others are trading near buy points coming out of a week marked by Nvidia earnings.
3 No-Brainer Stocks to Buy in September
07:30am, Saturday, 31'st Aug 2024
Eli Lilly is a growth machine that never runs out of opportunities. Novo Nordisk is still gaining momentum.
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now
07:10am, Saturday, 31'st Aug 2024
Eli Lilly and Novo Nordisk compete in a handful of different markets. Novo Nordisk is scaling up its output and upgrading its medicines a bit more slowly.
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000
05:40am, Saturday, 31'st Aug 2024
Healthcare and pet spending continue to perform in a wide range of economic environments. Eli Lilly is a storied business, raking in cash and profits while paving the way to a stronger future.
Stock Market This Week: NVDA Down, CRWD Reignites Confidence, LLY Cuts Zepbound Costs
05:02pm, Friday, 30'th Aug 2024
A late-day rally on Friday helped close the Dow Jones Industrial Average ($DJI) on yet another all-time high. As for the week, Oliver Renick takes a look at the headlines showcasing the highs and lows
Eli Lilly Could Become the First $1 Trillion Drug Stock. How Weight-Loss Drugs Can Get It There.
01:14pm, Friday, 30'th Aug 2024
The GLP-1 drug giant's shares have surged this year. Eli Lilly could keep climbing thanks to strong demand for Mounjaro and Zepbound.
Think Eli Lilly Stock Has Peaked? These 10 Words From the CEO May Change Your Mind
07:45am, Friday, 30'th Aug 2024
Eli Lilly has been rolling out Zepbound in recent months, and demand has been "unbelievable," says the CEO. Sales have been taking off, and that's even without spending aggressively on sales and marke
Lilly (LLY) Is Considered a Good Investment by Brokers: Is That True?
10:31am, Thursday, 29'th Aug 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
2 non-tech stocks hit $1 trillion market cap in 2025
06:24am, Thursday, 29'th Aug 2024
Achieving a $1 trillion market capitalization has long been a prestigious milestone in the stock market, with many companies striving to reach this level.
Is Eli Lilly Stock a No-Brainer Buy After the Company's Brilliant Zepbound Move?
05:44am, Thursday, 29'th Aug 2024
Lilly is making its obesity drug Zepbound available at less than half the cost of the list price of other GLP-1 drugs. The move is brilliant because it should expand the potential market for Zepbound.
Eli Lilly Launches Discounted Versions of Obesity Drug Zepbound
02:20pm, Wednesday, 28'th Aug 2024
LLY's single-dose vials are priced at least 50% lower than the list price of all other GLP-1 medicines for obesity.
